How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Asian stocks rise; FX lack direction on steady dollar, Fed rate-cut bets
China's 2025 copper imports lowest since 2020 amid major price rally
Trilateral links will boost growth
Strong growth for Malaysia's Islamic banking sector - S&P Global Ratings
Oil prices pause gains as Venezuela shipments resume but Iran concerns loom
Saks Global files for bankruptcy after Neiman Marcus takeover leads to financial collapse
Asian stocks inch higher, fragile yen spurs intervention worries�
FBM KLCI struggles to extend gains amid profit-taking pressure
China's trade ends 2025 with record trillion-dollar surplus despite Trump tariffs
Netflix prepares all-cash offer for Warner Bros, source says

Others Also Read